-
公开(公告)号:US20150099720A1
公开(公告)日:2015-04-09
申请号:US14519053
申请日:2014-10-20
Applicant: Ligand Pharmaceuticals Incorporated
Inventor: Lin Zhi , Robert I. Higuchi , E. Adam Kallel , Cornelis Arjan Van Oeveren , Jyun-Hung Chen , Daniel A. Ruppar , Bijan Pedram , Thomas Lot Stevens Lau , Todd A. Miller
IPC: C07C211/52 , C07F7/18 , C07D207/27 , C07C205/55 , C07D209/12 , C07D211/60 , C07D211/22 , C07C255/58 , C07D207/08
CPC classification number: C07C211/52 , C07C205/55 , C07C255/58 , C07C2601/08 , C07D207/08 , C07D207/09 , C07D207/12 , C07D207/16 , C07D207/26 , C07D207/27 , C07D207/46 , C07D209/04 , C07D209/08 , C07D209/12 , C07D211/22 , C07D211/56 , C07D211/60 , C07D215/04 , C07D215/18 , C07D265/36 , C07D295/073 , C07F7/1804 , G01N2333/723
Abstract: Provided herein are compounds having a structure selected from among Formula (I), Formula (II), Formula (III), Formula (IV), Formula (V) and Formula (VI) that are androgen receptor modulators and/or androgen receptor binding agents. Also disclosed are methods of making and using such compounds, including, but not limited to, using such compounds for treating various conditions.
Abstract translation: 本文提供具有选自式(I),式(II),式(III),式(IV),式(V)和式(VI))的结构的化合物,其是雄激素受体调节剂和/或雄激素受体结合 代理商 还公开了制备和使用这些化合物的方法,包括但不限于使用这些化合物来处理各种条件。
-
公开(公告)号:US20140005186A1
公开(公告)日:2014-01-02
申请号:US13974937
申请日:2013-08-23
Applicant: Ligand Pharmaceuticals Incorporated
Inventor: Lin Zhi , Robert I. Higuchi , E. Adam Kallel , Cornelis Arjan Van Oeveren , Jyun-Hung Chen , Daniel A. Ruppar , Bijan Pedram , Thomas Lot Stevens Lau , Todd A. Miller
IPC: C07D265/36 , C07D207/46 , C07D209/04 , C07D215/04 , C07D211/56
CPC classification number: C07C211/52 , C07C205/55 , C07C255/58 , C07C2601/08 , C07D207/08 , C07D207/09 , C07D207/12 , C07D207/16 , C07D207/26 , C07D207/27 , C07D207/46 , C07D209/04 , C07D209/08 , C07D209/12 , C07D211/22 , C07D211/56 , C07D211/60 , C07D215/04 , C07D215/18 , C07D265/36 , C07D295/073 , C07F7/1804 , G01N2333/723
Abstract: Provided herein are compounds having a structure selected from among Formula (I), Formula (II), Formula (III), Formula (IV), Formula (V) and Formula (VI) that are androgen receptor modulators and/or androgen receptor binding agents. Also disclosed are methods of making and using such compounds, including, but not limited to, using such compounds for treating various conditions.
Abstract translation: 本文提供具有选自式(I),式(II),式(III),式(IV),式(V)和式(VI))的结构的化合物,其是雄激素受体调节剂和/或雄激素受体结合 代理商 还公开了制备和使用这些化合物的方法,包括但不限于使用这些化合物来处理各种条件。
-